Calithera Biosciences Inc. | Mutual Funds
Mutual Funds that own Calithera Biosciences Inc.
Federated Kaufmann Fund
1,340,500
3.73%
1,340,500
0.11%
06/29/2018
iShares Russell 2000 ETF
713,278
1.98%
-381
0.01%
09/06/2018
Vanguard Total Stock Market Index Fund
703,130
1.95%
0
0%
07/31/2018
Federated Kaufmann Small Cap Fund
513,100
1.43%
513,100
0.17%
06/29/2018
iShares Nasdaq Biotechnology ETF
417,207
1.15%
-5,460
0.02%
09/06/2018
Vanguard Extended Market Index Fund
372,022
1.03%
0
0%
07/31/2018
American Century Small Company Fund
299,684
0.83%
-135,293
0.23%
06/30/2018
iShares Russell 2000 Value ETF
295,878
0.82%
0
0.02%
09/06/2018
Franklin Biotechnology Discovery Fund
275,500
0.77%
0
0.1%
03/31/2018
Wellington Mgmt. Port (Dublin) Plc - Global Health Care Eq.
271,885
0.76%
22,885
0.07%
12/31/2017
| Address |
343 Oyster Point Boulevard
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.calithera.com |
| Updated |
07/08/2019 |
| Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. |
